ALMS insider transaction filings
ALUMIS INC. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-09. Screen ALMS transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 13 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 1 filing by 1 insider — 986,721 shares, $10,726,255 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 9 legs across 8 filings by 7 insiders — 116,084 shares, $1,548,339 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: purchase of 273,291 shares @ $10.63 ($2,904,291) by AKKARAJU SRINIVAS, filed 2026-09-09.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| AKKARAJU SRINIVAS — Director | 2 | 4 legs · 986,721 sh · $10,726,255 | 2 legs · 96,131 sh · $1,014,028 | 2 |
| Pangali Sanam — Chief Legal Officer | 2 | — | 2 legs · 6,364 sh · $175,969 | 2 |
| Schroer John R. — Chief Financial Officer | 1 | — | 1 leg · 3,282 sh · $86,546 | — |
| Hardiman Roy C. — Chief Business & Strategy Ofcr | 1 | — | 1 leg · 2,692 sh · $70,988 | — |
| Goldstein David M — Chief Scientific Officer | 1 | — | 1 leg · 2,596 sh · $68,457 | — |
| Bradley Mark Christopher — Chief Development Officer | 1 | — | 1 leg · 2,572 sh · $67,824 | — |
| Drappa Jorn — Chief Medical Officer | 1 | — | 1 leg · 2,447 sh · $64,527 | — |
| Machado Patrick — Director | 1 | — | — | 2 |
| Srivastava Sapna — Director | 1 | — | — | 2 |
| TETRAULT LYNN A. — Director | 1 | — | — | 2 |
+1 more insider in the window, not shown — every filing appears in the table below.
Recent Form 4 filings — ALUMIS INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-09 | 4 | AKKARAJU SRINIVAS — Director | Purchase (P): 220,070 @ $11.17 · Purchase (P): 220,070 @ $11.17 · Sale (S): 48,066 @ $10.55 · Sale (S): 48,065 @ $10.55 · Purchase (P): 273,291 @ $10.63 · Purchase (P): 273,290 @ $10.63 | EDGAR |
| 2026-08-05 | 4 | Schroer John R. — Chief Financial Officer | Sale (S): 3,282 @ $26.37 | EDGAR |
| 2026-08-05 | 4 | Pangali Sanam — Chief Legal Officer | Sale (S): 1,364 @ $26.37 | EDGAR |
| 2026-08-05 | 4 | Hardiman Roy C. — Chief Business & Strategy Ofcr | Sale (S): 2,692 @ $26.37 | EDGAR |
| 2026-08-05 | 4 | Goldstein David M — Chief Scientific Officer | Sale (S): 2,596 @ $26.37 | EDGAR |
| 2026-08-05 | 4 | Drappa Jorn — Chief Medical Officer | Sale (S): 2,447 @ $26.37 | EDGAR |
| 2026-08-05 | 4 | Bradley Mark Christopher — Chief Development Officer | Sale (S): 2,572 @ $26.37 | EDGAR |
| 2026-07-08 | 4 | Pangali Sanam — Chief Legal Officer | Option exercise (M): 5,000 @ $5.06 · Sale (S): 5,000 @ $28 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | TETRAULT LYNN A. — Director | Grant/award (A): 3,553 @ $0 · Grant/award (A): 15,528 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Srivastava Sapna — Director | Grant/award (A): 3,553 @ $0 · Grant/award (A): 15,528 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Yao Zhengbin — Director | Grant/award (A): 3,553 @ $0 · Grant/award (A): 15,528 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Machado Patrick — Director | Grant/award (A): 3,553 @ $0 · Grant/award (A): 15,528 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | AKKARAJU SRINIVAS — Director | Grant/award (A): 3,553 @ $0 · Grant/award (A): 15,528 (derivative) @ $0 | EDGAR |
| 2026-05-27 | 4 | Drappa Jorn — Chief Medical Officer | Option exercise (M): 11,317 @ $8.84 · Option exercise (M): 15,535 @ $5.06 · Option exercise (M): 11,317 (derivative) @ $0 · Option exercise (M): 15,535 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Foresite Labs, LLC — 10% owner Foresite Labs Affiliates 2021, LLC — 10% owner | Other (J): 1,176,470 @ $0 · Other (J): 1,123,337 @ $0 · Other (J): 1,123,337 @ $0 · Other (J): 680,486 @ $0 | EDGAR |
| 2026-04-03 | 4 | Foresite Capital Management VI LLC — 10% owner Foresite Capital Management V, LLC — 10% owner Foresite Capital Fund V, L.P. — 10% owner Foresite Capital Opportunity Management V, LLC — 10% owner Foresite Capital Opportunity Fund V, L.P. — 10% owner Foresite Capital Fund VI LP — 10% owner Labs Co-Invest V, LLC — 10% owner Foresite Labs Management I, LLC — 10% owner Foresite Labs Fund I, L.P. — 10% owner | Other (J): 1,176,470 @ $0 · Other (J): 1,123,337 @ $0 · Other (J): 1,123,337 @ $0 · Other (J): 680,486 @ $0 | EDGAR |
| 2026-04-03 | 4 | Tananbaum James B. — Director, 10% owner | Other (J): 1,176,470 @ $0 · Other (J): 1,123,337 @ $0 · Other (J): 1,123,337 @ $0 · Other (J): 680,486 @ $0 | EDGAR |
| 2026-01-28 | 4 | Pangali Sanam — Chief Legal Officer | Grant/award (A): 186,200 (derivative) @ $0 | EDGAR |
| 2026-01-28 | 4 | Bradley Mark Christopher — Chief Development Officer | Grant/award (A): 190,225 (derivative) @ $0 | EDGAR |
| 2026-01-28 | 4 | Drappa Jorn — Chief Medical Officer | Grant/award (A): 221,450 (derivative) @ $0 | EDGAR |
| 2026-01-28 | 4 | Goldstein David M — Chief Scientific Officer | Grant/award (A): 216,675 (derivative) @ $0 | EDGAR |
| 2026-01-28 | 4 | Schroer John R. — Chief Financial Officer | Grant/award (A): 202,225 (derivative) @ $0 | EDGAR |
| 2026-01-28 | 4 | Hardiman Roy C. — Chief Business & Strategy Ofcr | Grant/award (A): 190,875 (derivative) @ $0 | EDGAR |
| 2026-01-28 | 4 | Babler Martin — President, CEO and Chairman, Director | Grant/award (A): 745,875 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | AKKARAJU SRINIVAS — Director | Purchase (P): 588,235 @ $17 | EDGAR |
| 2026-01-12 | 4 | Foresite Labs, LLC — 10% owner Foresite Labs Affiliates 2021, LLC — 10% owner | Purchase (P): 117,647 @ $17 · Purchase (P): 294,117 @ $17 | EDGAR |
| 2026-01-12 | 4 | Foresite Capital Management VI LLC — 10% owner Foresite Capital Management V, LLC — 10% owner Foresite Capital Fund V, L.P. — 10% owner Foresite Capital Opportunity Management V, LLC — 10% owner Foresite Capital Opportunity Fund V, L.P. — 10% owner Foresite Capital Fund VI LP — 10% owner Labs Co-Invest V, LLC — 10% owner Foresite Labs Management I, LLC — 10% owner Foresite Labs Fund I, L.P. — 10% owner | Purchase (P): 117,647 @ $17 · Purchase (P): 294,117 @ $17 | EDGAR |
| 2026-01-12 | 4 | Tananbaum James B. — Director, 10% owner | Purchase (P): 117,647 @ $17 · Purchase (P): 294,117 @ $17 | EDGAR |
| 2025-12-09 | 4 | AKKARAJU SRINIVAS — Director | Purchase (P): 64,969 @ $8.95 · Purchase (P): 70,028 @ $10.01 · Purchase (P): 51,380 @ $10.73 | EDGAR |
| 2025-12-04 | 4 | AKKARAJU SRINIVAS — Director | Purchase (P): 96,000 @ $7.55 · Purchase (P): 100,000 @ $7.75 · Purchase (P): 66,027 @ $8.18 | EDGAR |
| 2025-12-01 | 4 | AKKARAJU SRINIVAS — Director | Purchase (P): 48,537 @ $7.64 · Purchase (P): 38,702 @ $7.64 · Purchase (P): 86,350 @ $7.46 | EDGAR |
| 2025-11-25 | 4 | Foresite Labs, LLC — 10% owner Foresite Labs Affiliates 2021, LLC — 10% owner | Purchase (P): 72,212 @ $7.38 | EDGAR |
| 2025-11-25 | 4 | Foresite Capital Management VI LLC — 10% owner Foresite Capital Management V, LLC — 10% owner Foresite Capital Fund V, L.P. — 10% owner Foresite Capital Opportunity Management V, LLC — 10% owner Foresite Capital Opportunity Fund V, L.P. — 10% owner Foresite Capital Fund VI LP — 10% owner Labs Co-Invest V, LLC — 10% owner Foresite Labs Management I, LLC — 10% owner Foresite Labs Fund I, L.P. — 10% owner | Purchase (P): 72,212 @ $7.38 | EDGAR |
| 2025-11-25 | 4 | Tananbaum James B. — Director, 10% owner | Purchase (P): 72,212 @ $7.38 | EDGAR |
| 2025-11-24 | 4 | AKKARAJU SRINIVAS — Director | Purchase (P): 125,743 @ $7.20 | EDGAR |
| 2025-11-19 | 4 | Foresite Labs, LLC — 10% owner Foresite Labs Affiliates 2021, LLC — 10% owner | Purchase (P): 50,000 @ $5.60 · Purchase (P): 150,000 @ $5.59 · Purchase (P): 117,374 @ $6.19 · Purchase (P): 190,500 @ $6.56 | EDGAR |
| 2025-11-19 | 4 | Foresite Capital Management VI LLC — 10% owner Foresite Capital Management V, LLC — 10% owner Foresite Capital Fund V, L.P. — 10% owner Foresite Capital Opportunity Management V, LLC — 10% owner Foresite Capital Opportunity Fund V, L.P. — 10% owner Foresite Capital Fund VI LP — 10% owner Labs Co-Invest V, LLC — 10% owner Foresite Labs Management I, LLC — 10% owner Foresite Labs Fund I, L.P. — 10% owner | Purchase (P): 50,000 @ $5.60 · Purchase (P): 150,000 @ $5.59 · Purchase (P): 117,374 @ $6.19 · Purchase (P): 190,500 @ $6.56 | EDGAR |
| 2025-11-19 | 4 | Tananbaum James B. — Director, 10% owner | Purchase (P): 50,000 @ $5.60 · Purchase (P): 150,000 @ $5.59 · Purchase (P): 117,374 @ $6.19 · Purchase (P): 190,500 @ $6.56 | EDGAR |
| 2025-11-19 | 4 | AKKARAJU SRINIVAS — Director | Purchase (P): 914 @ $5.51 · Purchase (P): 102,652 @ $6.05 · Purchase (P): 137,772 @ $6.56 | EDGAR |
| 2025-11-17 | 4 | AKKARAJU SRINIVAS — Director | Purchase (P): 276,179 @ $5.25 | EDGAR |
| 2025-08-01 | 4 | TETRAULT LYNN A. — Director | Grant/award (A): 49,800 (derivative) @ $0 | EDGAR |
| 2025-08-01 | 4 | Srivastava Sapna — Director | Grant/award (A): 49,800 (derivative) @ $0 | EDGAR |
| 2025-08-01 | 4 | Yao Zhengbin — Director | Grant/award (A): 49,800 (derivative) @ $0 | EDGAR |
| 2025-08-01 | 4 | Machado Patrick — Director | Grant/award (A): 49,800 (derivative) @ $0 | EDGAR |
| 2025-08-01 | 4 | AKKARAJU SRINIVAS — Director | Grant/award (A): 49,800 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | Drappa Jorn — Chief Medical Officer | Grant/award (A): 25,450 @ $0 · Grant/award (A): 101,850 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | Goldstein David M — Chief Scientific Officer | Grant/award (A): 27,000 @ $0 · Grant/award (A): 107,950 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | Schroer John R. — Chief Financial Officer | Grant/award (A): 28,000 @ $0 · Grant/award (A): 111,950 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | Hardiman Roy C. — Chief Business & Strategy Ofcr | Grant/award (A): 28,000 @ $0 · Grant/award (A): 111,950 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | Babler Martin — President, CEO and Chairman, Director | Grant/award (A): 662,000 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — ALUMIS INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-01 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-10 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-02 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-29 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-19 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-09 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-06 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ALMS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →